Location History:
- St. Clair Shores, MI (US) (1978)
- Holland, MI (US) (1984)
Company Filing History:
Years Active: 1978-1984
Title: Walter E Behnke: Innovator in Pharmaceutical Chemistry
Introduction
Walter E Behnke is a notable inventor based in St. Clair Shores, MI (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as antihypertensive agents. With a total of 2 patents to his name, Behnke's work has had a meaningful impact on medical science.
Latest Patents
Behnke's latest patents include the production of phosphate salts of the substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acid. This process involves treating a suitably substituted octahydro-1H-indole with phosphoric acid. The resulting phosphate salts and pharmaceutical compositions are recognized for their utility as antihypertensive agents. Another significant patent details the process for producing 9-(.beta.-D-arabinofuranosyl)adenine, specifically an ester product, 9-(.beta.-D-arabinofuranosyl)adenine, 5'-phosphate. This process includes a series of steps involving the reaction of 9-(.beta.-D-arabinofuranosyl)adenine with a phosphorylating agent in a trialkyl phosphate solvent, followed by aqueous hydrolysis and product isolation.
Career Highlights
Walter E Behnke has been associated with Warner-Lambert Company, where he has applied his expertise in pharmaceutical development. His innovative approaches have contributed to advancements in drug formulation and therapeutic applications.
Collaborations
Throughout his career, Behnke has collaborated with notable colleagues, including Ronald E Seamans and William R Marsh. These partnerships have fostered a collaborative environment that has enhanced the quality and scope of their research.
Conclusion
Walter E Behnke's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field, particularly in the development of effective antihypertensive agents.